×
The protein-based vaccine, called Nuvaxovid, has been reformulated to target the JN.1 subvariant of Omicron. (The Canadian Press)

Health Canada approves updated Novavax COVID-19 vaccine

By The Canadian Press Sep 19, 2024 | 2:23 PM